Matthew Scalo

Matthew Scalo

Investor Relations Contact chez MYRIAD GENETICS, INC.
Finance
Health Technology
Consumer Services

Profil

Matthew Scalo is Senior Vice President-Investor Relations at Myriad Genetics, Inc. since 2022.
Former roles include Senior Director-Investor Relations at Luminex Corp., Investor Relations Contact at NextGen Healthcare, Inc., Senior Research Analyst at Allspring Global Investments LLC, Research Analyst at Canaccord Adams, Inc. from 2004 to 2010, VP, Investor Relations & Corporate Development at Cutera, Inc., Associate at Broadpoint.
Gleacher Securities in 2003, and Research Analyst at Canaccord Genuity, Inc. in 2010.
Education includes an MBA from the University of Notre Dame and an undergraduate degree from the University of California, Davis.

Postes actifs de Matthew Scalo

SociétésPosteDébut
MYRIAD GENETICS, INC. Investor Relations Contact 01/08/2022

Anciens postes connus de Matthew Scalo

SociétésPosteFin
Analyst-Equity 31/12/2010
Analyst-Equity 22/04/2010
Analyst-Equity 31/12/2003
Analyst-Equity 31/12/2002
NEXTGEN HEALTHCARE, INC. Investor Relations Contact -
Voir l'expérience en détail de Matthew Scalo

Formation de Matthew Scalo

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

78

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Technology Services

Health Technology

Finance

Health Technology

Finance

Health Technology

Consumer Services

Finance

Consumer Services

Finance

  1. Bourse
  2. Insiders
  3. Matthew Scalo
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT